PITX2 as a Sensitive and Specific Marker of Midgut Neuroendocrine Tumors: Results from a Cohort of 1157 Primary Neuroendocrine Neoplasms

被引:3
|
作者
Grass, Albert [1 ,2 ]
Kasajima, Atsuko [3 ]
Foersch, Sebastian [4 ]
Kriegsmann, Mark [5 ]
Brobeil, Alexander [5 ]
Schmitt, Maxime [1 ,2 ]
Wagner, Daniel [4 ]
Poppinga, Jelte [2 ,6 ]
Wiese, Dominik [2 ,6 ]
Maurer, Elisabeth [2 ,6 ]
Kirschbaum, Andreas [2 ,6 ]
Muley, Thomas [7 ,8 ]
Winter, Hauke [7 ,8 ,9 ]
Rinke, Anja [2 ,10 ]
Gress, Thomas M. [2 ,10 ]
Kremer, Markus [11 ]
Evert, Matthias [12 ]
Maerkl, Bruno [13 ]
Quaas, Alexander [14 ]
Eckstein, Markus [15 ]
Tschurtschenthaler, Markus [16 ]
Kloeppel, Guenter [3 ]
Denkert, Carsten [1 ,2 ]
Bartsch, Detlef K. [2 ,6 ]
Jesinghaus, Moritz [1 ,2 ]
机构
[1] Phillips Univ Marburg, Dept Pathol, Marburg, Germany
[2] Univ Hosp Marburg, Marburg, Germany
[3] Tech Univ Munich, Dept Pathol, Munich, Germany
[4] Univ Hosp Mainz, Dept Pathol, Mainz, Germany
[5] Univ Hosp Heidelberg, Dept Pathol, Heidelberg, Germany
[6] Phillips Univ Marburg, Dept Surg, Marburg, Germany
[7] Translat Lung Res Ctr Heidelberg TLRC H, Heidelberg, Germany
[8] Heidelberg Univ Hosp, Translat Res Unit, Thoraxklin, Heidelberg, Germany
[9] Heidelberg Univ Hosp, Dept Thorac Surg, Thoraxklin, Heidelberg, Germany
[10] Phillips Univ Marburg, Dept Gastroenterol Endocrinol & Infect Dis, Marburg, Germany
[11] Stadt Klinikum Munchen, Inst Pathol, Munich, Germany
[12] Univ Hosp Regensburg, Dept Pathol, Regensburg, Germany
[13] Univ Hosp Augsburg, Inst Pathol, Augsburg, Germany
[14] Univ Hosp Cologne, Inst Pathol, Cologne, Germany
[15] Friedrich Alexander Univ Erlangen Nurnberg, Dept Pathol, Univ Hosp Erlangen, Erlangen, Germany
[16] German Canc Consortium DKTK, Inst Translat Canc Res, Partner Site Munich, Munich, Germany
关键词
midgut; neuroendocrine carcinoma; neuroendocrine neoplasms; neuroendocrine tumor; Pituitary Homeobox 2; CLASSIFICATION; CARCINOIDS; CDX-2; TTF-1; IRS;
D O I
10.1016/j.modpat.2024.100442
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
As neuroendocrine tumors (NETs) often present as metastatic lesions, immunohistochemical assignment to a site of origin is one of the most important tasks in their pathologic assessment. Because a fraction of NETs eludes the typical expression profiles of their primary localization, additional sensitive and specific markers are required to improve diagnostic certainty. We investigated the expression of the transcription factor Pituitary Homeobox 2 (PITX2) in a large-scale cohort of 909 NET and 248 neuroendocrine carcinomas (NEC) according to the immunoreactive score (IRS) and correlated PITX2 expression groups with general tumor groups and primary localization. PITX2 expression (all expression groups) was highly sensitive (98.1%) for midgut-derived NET, but not perfectly specific, as non-midgut NET (especially pulmonary/duodenal) were quite frequently weak or moderately positive. The specificity rose to 99.5% for a midgut origin of NET if only a strong PITX2 expression was considered, which was found in only 0.5% (one pancreatic/one pulmonary) of non-midgut NET. In metastases of midgut-derived NET, PITX2 was expressed in all cases (87.5% strong, 12.5% moderate), whereas CDX2 was negative or only weakly expressed in 31.3% of the metastases. In NEC, a fraction of cases (14%) showed a weak or moderate PITX2 expression, which was not associated with a specific tumor localization. Our study independently validates PITX2 as a very sensitive and specific immunohistochemical marker of midgut-derived NET in a very large collective of neuroendocrine neoplasms. Therefore, our data argue toward implementation into diagnostic panels applied for NET as a firstline midgut marker. (c) 2024 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology. This is an open access article under the CC BY -NC -ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Sex comb on midleg like-2 is a novel specific marker for the diagnosis of gastroenteropancreatic neuroendocrine tumors
    Yang, Jiao-Jiao
    Huang, Hua
    Xiao, Ming-Bing
    Jiang, Feng
    Ni, Wen-Kai
    Ji, Yi-Fei
    Lu, Cui-Hua
    Ni, Run-Zhou
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (02) : 1749 - 1755
  • [32] ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
    Pavel, Marianne
    Baudin, Eric
    Couvelard, Anne
    Krenning, Eric
    Oberg, Kjell
    Steinmueller, Thomas
    Anlauf, Martin
    Wiedenmann, Bertram
    Salazar, Ramon
    NEUROENDOCRINOLOGY, 2012, 95 (02) : 157 - 176
  • [33] INSM1 Is a Highly Specific Marker of Neuroendocrine Differentiation in Primary Neoplasms of the Gastrointestinal Tract, Appendix, and Pancreas An Immunohistochemical Study of 179 Cases
    McHugh, Kelsey E.
    Mukhopadhyay, Sanjay
    Doxtader, Erika E.
    Lanigan, Christopher
    Allende, Daniela S.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 153 (06) : 811 - 820
  • [34] SATB2 protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours
    Hoskoppal, Deepthi
    Epstein, Jonathan, I
    Gown, Allen M.
    Egloff, Shanna A. Arnold
    Gordetsky, Jennifer B.
    Shi, Chanjuan J.
    Giannico, Giovanna A.
    HISTOPATHOLOGY, 2020, 76 (04) : 550 - 559
  • [35] Particular efficacy of PRRT in midgut neuroendocrine tumors G1-2: A cohort study with standard 177Lu-octreotate therapy
    Sabet, Amir
    Dautzenberg, Kristina
    Haslerud, Torjan
    Aouf, Anas
    Sabet, Amin
    Simon, Birgit
    Mayer, Karin
    Biersack, Hans
    Ezziddin, Samer
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [36] Complications After Major Surgery for Duodenopancreatic Neuroendocrine Tumors in Patients with MEN1: Results from a Nationwide Cohort
    van Beek, Dirk-Jan
    Nell, Sjoerd
    Vorselaars, Wessel M. C. M.
    Bonsing, Bert A.
    van Eijck, Casper H. J.
    van Goor, Harry
    Nieveen van Dijkum, Elisabeth J.
    Dejong, Cornelis H. C.
    Valk, Gerlof D.
    Rinkes, Inneh. M. Borel
    Vriens, Menno R.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (08) : 4387 - 4399
  • [37] Complications After Major Surgery for Duodenopancreatic Neuroendocrine Tumors in Patients with MEN1: Results from a Nationwide Cohort
    Dirk-Jan van Beek
    Sjoerd Nell
    Wessel M. C. M. Vorselaars
    Bert A. Bonsing
    Casper H. J. van Eijck
    Harry van Goor
    Elisabeth J. Nieveen van Dijkum
    Cornelis H. C. Dejong
    Gerlof D. Valk
    Inne H. M. Borel Rinkes
    Menno R. Vriens
    Annals of Surgical Oncology, 2021, 28 : 4387 - 4399
  • [38] Identification of Mac-2-binding Protein as a Putative Marker of Neuroendocrine Tumors from the Analysis of Cell Line Secretomes
    Srirajaskanthan, Rajaventhan
    Caplin, Martyn E.
    Waugh, Mark G.
    Watkins, Jennifer
    Meyer, Tim
    Hsuan, J. Justin
    Beaumont, Nicholas J.
    MOLECULAR & CELLULAR PROTEOMICS, 2010, 9 (04) : 656 - 666
  • [39] POU2F3: A Sensitive and Specific Diagnostic Marker for Neuroendocrine-low/negative Small Cell Lung Cancer
    Wang, Yue
    Jin, Yan
    Shen, Xuxia
    Zheng, Qiang
    Xue, Qianqian
    Chen, Lijun
    Lin, Yicong
    Li, Yuan
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2023, 47 (09) : 1059 - 1066
  • [40] Primary vs metastatic pulmonary adenocarcinoma: Cdx-2 is a specific and sensitive marker of tumors of colonic origin
    Murer, B
    Chilosi, M
    Barbareschi, M
    Macri, E
    Loda, M
    Doglioni, C
    MODERN PATHOLOGY, 2002, 15 (01) : 325A - 326A